Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7902 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.7843 |
Intermediate Similarity |
NPD7236 |
Approved |
0.7818 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7707 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.7665 |
Intermediate Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7602 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.7529 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.7482 |
Intermediate Similarity |
NPD2629 |
Approved |
0.7457 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD7741 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7351 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.733 |
Intermediate Similarity |
NPD8361 |
Approved |
0.733 |
Intermediate Similarity |
NPD8360 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7058 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD7057 |
Phase 3 |
0.7232 |
Intermediate Similarity |
NPD8435 |
Approved |
0.7202 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7194 |
Intermediate Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.7119 |
Intermediate Similarity |
NPD8424 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7105 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7088 |
Intermediate Similarity |
NPD8485 |
Approved |
0.707 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.707 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.707 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7066 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7066 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7066 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.705 |
Intermediate Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7048 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7044 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD7008 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7029 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7022 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7007 |
Intermediate Similarity |
NPD7457 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7274 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD37 |
Approved |
0.6982 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6973 |
Remote Similarity |
NPD8486 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD5844 |
Phase 1 |
0.6948 |
Remote Similarity |
NPD6663 |
Approved |
0.6948 |
Remote Similarity |
NPD7961 |
Discontinued |
0.6946 |
Remote Similarity |
NPD7819 |
Suspended |
0.6944 |
Remote Similarity |
NPD4198 |
Discontinued |
0.6939 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6939 |
Remote Similarity |
NPD5126 |
Approved |
0.6932 |
Remote Similarity |
NPD6765 |
Approved |
0.6932 |
Remote Similarity |
NPD6764 |
Approved |
0.6929 |
Remote Similarity |
NPD2182 |
Approved |
0.6923 |
Remote Similarity |
NPD7075 |
Discontinued |
0.6909 |
Remote Similarity |
NPD6591 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD7228 |
Approved |
0.6875 |
Remote Similarity |
NPD5951 |
Approved |
0.6875 |
Remote Similarity |
NPD690 |
Clinical (unspecified phase) |
0.6868 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6864 |
Remote Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.6862 |
Remote Similarity |
NPD7497 |
Discontinued |
0.6859 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6845 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6832 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6812 |
Remote Similarity |
NPD6647 |
Phase 2 |
0.6805 |
Remote Similarity |
NPD5402 |
Approved |
0.6802 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6797 |
Remote Similarity |
NPD5736 |
Approved |
0.6792 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6786 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6786 |
Remote Similarity |
NPD6685 |
Approved |
0.6778 |
Remote Similarity |
NPD6784 |
Approved |
0.6778 |
Remote Similarity |
NPD6785 |
Approved |
0.6768 |
Remote Similarity |
NPD2533 |
Approved |
0.6768 |
Remote Similarity |
NPD2532 |
Approved |
0.6768 |
Remote Similarity |
NPD2534 |
Approved |
0.6766 |
Remote Similarity |
NPD6599 |
Discontinued |
0.676 |
Remote Similarity |
NPD8313 |
Approved |
0.676 |
Remote Similarity |
NPD8312 |
Approved |
0.6753 |
Remote Similarity |
NPD8462 |
Phase 1 |
0.6752 |
Remote Similarity |
NPD6355 |
Discontinued |
0.675 |
Remote Similarity |
NPD5763 |
Approved |
0.675 |
Remote Similarity |
NPD7266 |
Discontinued |
0.675 |
Remote Similarity |
NPD5762 |
Approved |
0.6743 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6742 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6732 |
Remote Similarity |
NPD5740 |
Clinical (unspecified phase) |
0.6732 |
Remote Similarity |
NPD6085 |
Phase 2 |
0.6713 |
Remote Similarity |
NPD4141 |
Clinical (unspecified phase) |
0.6711 |
Remote Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.6709 |
Remote Similarity |
NPD6653 |
Approved |
0.6707 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6707 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6705 |
Remote Similarity |
NPD3818 |
Discontinued |
0.6689 |
Remote Similarity |
NPD9545 |
Approved |
0.6687 |
Remote Similarity |
NPD5403 |
Approved |
0.6687 |
Remote Similarity |
NPD7137 |
Phase 2 |
0.6685 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6667 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD8389 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6648 |
Remote Similarity |
NPD7240 |
Approved |
0.6647 |
Remote Similarity |
NPD5494 |
Approved |
0.6647 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6647 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.6646 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6646 |
Remote Similarity |
NPD7702 |
Clinical (unspecified phase) |
0.6643 |
Remote Similarity |
NPD164 |
Approved |
0.6629 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6628 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6627 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6626 |
Remote Similarity |
NPD7003 |
Approved |
0.6626 |
Remote Similarity |
NPD3750 |
Approved |
0.6625 |
Remote Similarity |
NPD7305 |
Phase 1 |
0.6625 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6623 |
Remote Similarity |
NPD4807 |
Approved |
0.6623 |
Remote Similarity |
NPD4806 |
Approved |
0.6623 |
Remote Similarity |
NPD6287 |
Discontinued |
0.6621 |
Remote Similarity |
NPD7094 |
Approved |
0.6621 |
Remote Similarity |
NPD6858 |
Approved |
0.6616 |
Remote Similarity |
NPD8404 |
Phase 2 |
0.6608 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.6608 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6607 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6606 |
Remote Similarity |
NPD6799 |
Approved |
0.6605 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.66 |
Remote Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.66 |
Remote Similarity |
NPD5306 |
Approved |
0.66 |
Remote Similarity |
NPD5305 |
Approved |
0.6594 |
Remote Similarity |
NPD1238 |
Approved |
0.659 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6588 |
Remote Similarity |
NPD1934 |
Approved |
0.6587 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6573 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6571 |
Remote Similarity |
NPD1931 |
Clinical (unspecified phase) |
0.6571 |
Remote Similarity |
NPD1929 |
Approved |
0.6571 |
Remote Similarity |
NPD5738 |
Clinical (unspecified phase) |
0.6571 |
Remote Similarity |
NPD5765 |
Approved |
0.6571 |
Remote Similarity |
NPD1930 |
Approved |
0.657 |
Remote Similarity |
NPD3882 |
Suspended |
0.6568 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6566 |
Remote Similarity |
NPD5401 |
Approved |
0.6552 |
Remote Similarity |
NPD6912 |
Phase 3 |
0.6536 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6529 |
Remote Similarity |
NPD7411 |
Suspended |
0.6528 |
Remote Similarity |
NPD2067 |
Discontinued |
0.6525 |
Remote Similarity |
NPD1237 |
Approved |
0.6524 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6524 |
Remote Similarity |
NPD2575 |
Approved |
0.6524 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6524 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.651 |
Remote Similarity |
NPD7610 |
Discontinued |
0.6509 |
Remote Similarity |
NPD3226 |
Approved |
0.6508 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6508 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6497 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.6497 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.6497 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.6481 |
Remote Similarity |
NPD2438 |
Suspended |
0.648 |
Remote Similarity |
NPD7054 |
Approved |
0.6479 |
Remote Similarity |
NPD5048 |
Discontinued |
0.6478 |
Remote Similarity |
NPD4140 |
Approved |
0.6477 |
Remote Similarity |
NPD8319 |
Approved |
0.6477 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6474 |
Remote Similarity |
NPD3664 |
Approved |
0.6474 |
Remote Similarity |
NPD3661 |
Approved |
0.6474 |
Remote Similarity |
NPD5204 |
Approved |
0.6474 |
Remote Similarity |
NPD3662 |
Phase 3 |
0.6474 |
Remote Similarity |
NPD3663 |
Approved |
0.6456 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6453 |
Remote Similarity |
NPD2801 |
Approved |
0.6453 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6452 |
Remote Similarity |
NPD3094 |
Phase 2 |
0.6447 |
Remote Similarity |
NPD4136 |
Approved |
0.6447 |
Remote Similarity |
NPD4135 |
Approved |
0.6447 |
Remote Similarity |
NPD4106 |
Approved |
0.6444 |
Remote Similarity |
NPD7472 |
Approved |
0.6442 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6438 |
Remote Similarity |
NPD969 |
Suspended |
0.6438 |
Remote Similarity |
NPD5735 |
Approved |
0.6436 |
Remote Similarity |
NPD6534 |
Approved |
0.6436 |
Remote Similarity |
NPD6535 |
Approved |
0.6434 |
Remote Similarity |
NPD7899 |
Clinical (unspecified phase) |
0.6433 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6432 |
Remote Similarity |
NPD7930 |
Approved |
0.6429 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6429 |
Remote Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.6425 |
Remote Similarity |
NPD7435 |
Discontinued |
0.642 |
Remote Similarity |
NPD3748 |
Approved |
0.642 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6415 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.6415 |
Remote Similarity |
NPD7715 |
Approved |
0.6415
|
Remote Similarity |
NPD6233 |
Phase 2 |